MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
*Architects: Pulmonology (Health IT, Devices & Technology)
Biodesix, Inc. (NASDAQ:BDSX)*
Organization & Developments: Biodesix
Parents
Biodesix, Inc. (NASDAQ:BDSX)*
Children
2022: A Second Look At Biodesix_seekingalpha.com
2022: Philips taps Biodesix's blood tests for lung cancer screening system
Biodesix is a molecular diagnostics company engaged in the development of innovative products for personalizing medicine.
Data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease
Developing diagnostic "classifiers"
Enabling personalized medicine by focusing on the unique characteristics of the patient using mass spectrometry based molecular
Focused on applying signal processing, statistical analysis, & understanding of the physics of mass spectrometers to build a bio
For use by researchers, drug developers and clinicians.
Rapid, cost-effective analyzing of proteins in patient samples
The ProTS Platform
These classifiers can reproducibly, reliably, and with clinically significant accuracy, predict and evaluate normal biologic or
VeriStrat is a proteomic serum test for patients with advanced non-small cell lung cancer (NSCLC).
VeriStrat™
Jumps
*Key People: Biodesix
Finance & Acquisitions: Biodesix